Fresh Off Tysabri Court Win, Biogen Idec Makes A Hostile Bid For Facet Biotech
This article was originally published in The Pink Sheet Daily
Executive Summary
Spun out of PDL Biopharma late last year, Facet already has a partnership with Biogen for oncology and multiple sclerosis programs.